Nov 13, 2019
Long-term blood pressure variation and risk of dementia
Study reports that people who experienced substantial changes in blood pressure over the long term were at greater risk of dementia than those who did not.
Nov 12, 2019
Wearable tracker study links insufficient sleep to biological aging and cardiovascular disease risk
Singapore study using wearable trackers links insufficient sleep to increased rate of biological aging and cardiovascular disease risk.
Nov 11, 2019
Researchers report new insights into Parkinson disease-related mortality
Study identifies risk factors associated with increased mortality in patients with Parkinson disease compared to the general population.
Nov 08, 2019
Potential treatment path becomes clear for subtype of Charcot-Marie-Tooth disease
Scripps Research scientists discover a way to stop a problematic enzyme from wreaking havoc on peripheral nervous system cells.
Nov 07, 2019
Study: Rapamycin prevents age-related brain vascular deterioration
Study shows age-related decreases in blood flow to the brain and memory loss can be modified with the drug rapamycin.
Nov 06, 2019
Trouble sleeping? Insomnia symptoms linked to increased risk of stroke, heart attack
Results suggest that targeting people who have trouble sleeping with behavioral therapies may reduce the number of cases of stroke, heart attack, and other diseases.
Nov 05, 2019
Stressed to the max? Deep sleep can rewire the anxious brain
A sleepless night can trigger up to a 30% rise in emotional stress levels, new study shows.
Nov 04, 2019
Study suggests acetaminophen exposure in pregnancy linked to higher risk of ADHD and autism
Researchers analyzed data from the Boston Birth Cohort.
Nov 01, 2019
Research explains why people with Down syndrome have spatial memory problems
The triplication of a single gene, GRIK1, located on chromosome 21, causes alterations in inhibitory synaptic transmission in the hippocampus, related to memory and space orientation.
Oct 30, 2019
FDA approves diroximel fumarate for relapsing forms of multiple sclerosis
Drug is a novel oral fumarate with a distinct chemical structure that is designed to impact its gastrointestinal tolerability.